{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:58:39Z","timestamp":1762077519852,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008935","name":"Center of Excellence in Regulatory Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005946"],"award-info":[{"award-number":["U01FD005946"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","jada.ada.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.adaj.2025.05.016","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T13:03:25Z","timestamp":1754312605000},"page":"638-648.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of drug-related oral and dental adverse events"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-3207","authenticated-orcid":false,"given":"Monisha","family":"Billings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0243-1096","authenticated-orcid":false,"given":"Hannah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyance L.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1365-0622","authenticated-orcid":false,"given":"Frederick","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-7595","authenticated-orcid":false,"given":"Darien","family":"Weatherspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-5226","authenticated-orcid":false,"given":"Vineet","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farbod","family":"Fazilatkhoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5279-6247","authenticated-orcid":false,"given":"Helen","family":"Edelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.adaj.2025.05.016_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws: 2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.adaj.2025.05.016_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0762.178742","article-title":"Medication-related osteonecrosis of the jaw: clinical and practical guidelines","volume":"6","author":"Rosella","year":"2016","journal-title":"J Int Soc Prev Community Dent"},{"issue":"1","key":"10.1016\/j.adaj.2025.05.016_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cden.2006.09.002","article-title":"Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions","volume":"51","author":"Clark","year":"2007","journal-title":"Dent Clin North Am"},{"issue":"6","key":"10.1016\/j.adaj.2025.05.016_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/odi.13680","article-title":"Oral adverse effects: drug-induced tongue disorders","volume":"27","author":"Aziz","year":"2021","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.adaj.2025.05.016_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1597\/05-208.1","article-title":"Drug treatment during pregnancy and isolated orofacial clefts in Hungary","volume":"44","author":"Puho","year":"2007","journal-title":"Cleft Palate Craniofac J"},{"issue":"4","key":"10.1016\/j.adaj.2025.05.016_bib6","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.adaj.2025.05.016_bib7","first-page":"102","article-title":"Cleft palate in HIV-exposed newborns of mothers on highly active antiretroviral therapy","volume":"7","author":"James","year":"2014","journal-title":"Oral Surg"},{"issue":"1","key":"10.1016\/j.adaj.2025.05.016_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oooo.2014.09.009","article-title":"Adverse drug events in the oral cavity","volume":"119","author":"Yuan","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"10.1016\/j.adaj.2025.05.016_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/154411130401500405","article-title":"Adverse drug reactions in the orofacial region","volume":"15","author":"Scully","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"issue":"3","key":"10.1016\/j.adaj.2025.05.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5005\/jcdp-9-3-1","article-title":"Current opinion on drug-induced oral reactions: a comprehensive review","volume":"9","author":"Abdollahi","year":"2008","journal-title":"J Contemp Dent Pract"},{"issue":"2","key":"10.1016\/j.adaj.2025.05.016_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2334\/josnusd.49.89","article-title":"Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation","volume":"49","author":"Ismail","year":"2007","journal-title":"J Oral Sci"},{"issue":"1","key":"10.1016\/j.adaj.2025.05.016_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/prd.12260","article-title":"Oral lichen planus: a disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies","volume":"80","author":"Carrozzo","year":"2019","journal-title":"Periodontol 2000"},{"issue":"6","key":"10.1016\/j.adaj.2025.05.016_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13947","article-title":"A case series of medication-related fibrovascular hyperplasia following hematopoietic stem cell transplantation for Fanconi anemia","volume":"25","author":"Ballardin","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.adaj.2025.05.016_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/scd.12497","article-title":"Medication-related fibrovascular hyperplasia lesion in tongue: case report","volume":"40","author":"Ballardin","year":"2020","journal-title":"Spec Care Dentist"},{"issue":"7","key":"10.1016\/j.adaj.2025.05.016_bib15","first-page":"867","article-title":"Generalized white appearance of the oral mucosa. Hyperkeratosis secondary to palifermin","volume":"141","author":"Lerman","year":"2010","journal-title":"JADA"},{"issue":"1","key":"10.1016\/j.adaj.2025.05.016_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2466\/pr0.2001.89.1.48","article-title":"Clinical assessment of tics","volume":"89","author":"Brasic","year":"2001","journal-title":"Psychol Rep"},{"issue":"11","key":"10.1016\/j.adaj.2025.05.016_bib17","first-page":"432","article-title":"SSRI-associated nocturnal bruxism in four patients","volume":"54","author":"Ellison","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.adaj.2025.05.016_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1345\/aph.17302","article-title":"Selective serotonin-reuptake inhibitor-induced movement disorders","volume":"32","author":"Gerber","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.adaj.2025.05.016_bib19","first-page":"340","article-title":"Reports of SSRI-associated bruxism in the family physician\u2019s office","volume":"15","author":"Lobbezoo","year":"2001","journal-title":"J Orofac Pain"},{"issue":"7","key":"10.1016\/j.adaj.2025.05.016_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14740338.2017.1323867","article-title":"Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)","volume":"16","author":"Alatawi","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.adaj.2025.05.016_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.adaj.2025.05.016_bib24","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817725003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817725003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:54:32Z","timestamp":1762077272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817725003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0002817725003551"],"URL":"https:\/\/doi.org\/10.1016\/j.adaj.2025.05.016","relation":{},"ISSN":["0002-8177"],"issn-type":[{"type":"print","value":"0002-8177"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of drug-related oral and dental adverse events","name":"articletitle","label":"Article Title"},{"value":"The Journal of the American Dental Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adaj.2025.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Dental Association. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}